EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer

Shi-Yang Li iD, Jan A Hammarlund, Gang Wu, Jia-Wen Lian iD, Sacha J Howell iD, Robert B Clarke, Antony D Adamson iD, Cátia F Gonçalves iD, John B Hogenesch iD, Ron C Anafi, Qing-Jun Meng iD

Proceedings of the National Academy of Sciences · 13.02.2024 · 121 (7)

DOI: 10.1073/pnas.2311854121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.02.2024. Verfasst von Shi-Yang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manc…. Hauptthemen laut MEDLINE: Breast Neoplasms, Circadian Clocks. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies in shift workers and model organisms link circadian disruption to breast cancer. However, molecular circadian rhythms in noncancerous and cancerous human breast tissues and their clinical relevance are largely unknown. We reconstructed rhythms informatically, integrating locally collected, time-stamped biopsies with public datasets. For noncancerous breast tissue, inflammatory, epithelial–mesenchymal transition (EMT), and estrogen responsiveness pathways show circadian modulation. Among tumors, clock correlation analysis demonstrates subtype-specific changes in circadian organization. Luminal A organoids and informatic ordering of luminal A samples exhibit continued, albeit dampened and reprogrammed rhythms. However, CYCLOPS magnitude, a measure of global rhythm strength, varied widely among luminal A samples. Cycling of EMT pathway genes was markedly increased in high-magnitude luminal A tumors. Surprisingly, patients with high-magnitude tumors had reduced 5-y survival. Correspondingly, 3D luminal A cultures show reduced invasion following molecular clock disruption. This study links subtype-specific circadian disruption in breast cancer to EMT, metastatic potential, and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCircadian ClocksHumansFemaleCircadian RhythmEstrogensPrognosis

Stichwörter der Autor:innen

breast cancercircadian data orderingcircadian medicinemetastasisprognosis

Substanzen

Estrogens

Autor:innen und Institutionen

  • Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.
  • School of Biomedical Engineering, Science and Health Systems, Bossone Research Center, Drexel University, Philadelphia, PA 19104.
  • Division of Human Genetics, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
  • Division of Immunobiology, Center for Circadian Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
  • Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M20 4GJ, United Kingdom.
  • Department of Medicine, Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

ORCID-Profile: Shi-Yang Li, Jia-Wen Lian, Sacha J Howell, Antony D Adamson, Cátia F Gonçalves, John B Hogenesch, Qing-Jun Meng

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • Wellcome Trust
  • Breast Cancer Now
  • HHS | NIH | National Cancer Institute
  • UKRI | Medical Research Council

Zitieren

APA

Li, S. Y., Hammarlund, J. A., Wu, G., Lian, J. W., Howell, S. J., Clarke, R. B., Adamson, A. D., Gonçalves, C. F., Hogenesch, J. B., Anafi, R. C., & Meng, Q. J. (2024). Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer. Proceedings of the National Academy of Sciences, 121(7). https://doi.org/10.1073/pnas.2311854121

Vancouver

Li SY, Hammarlund JA, Wu G, Lian JW, Howell SJ, Clarke RB, et al. Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer. Proceedings of the National Academy of Sciences. 2024;121(7). doi:10.1073/pnas.2311854121

BibTeX
@article{Li2024,
  author = {Li, Shi-Yang and Hammarlund, Jan A and Wu, Gang and Lian, Jia-Wen and Howell, Sacha J and Clarke, Robert B and Adamson, Antony D and Gonçalves, Cátia F and Hogenesch, John B and Anafi, Ron C and Meng, Qing-Jun},
  title = {Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {7},
  doi = {10.1073/pnas.2311854121}
}
Kostenlos starten →